Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy
Anne Perdrix, Nathalie Olympios, Jean Rouvet, Marie Degremont, Camille Fontaine, Baptiste Boitel, Roman Vion, Marianne Leheurteur, Florian Clatot
Topics & Concepts
PembrolizumabMedicineTriple-negative breast cancerBreast cancerOncologyInternal medicineImmunotherapyOvarian cancerCancerOvarian cancer diagnosis and treatmentReproductive Biology and FertilityCancer Risks and Factors